PKU gene study seeks clues in adult health
NCT ID NCT07484945
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how genes and body chemistry are linked in adults with phenylketonuria (PKU) who were treated early in life. Researchers will analyze blood and saliva samples from 149 participants to find patterns that may explain differences in health and thinking skills. No new treatment is being tested; the goal is to better understand the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Civil Hospitals
NOT_YET_RECRUITINGLyon, 69000, France
-
Conception hospital
NOT_YET_RECRUITINGMarseille, 13000, France
-
Necker hospital
NOT_YET_RECRUITINGParis, 75000, France
-
University hospital
NOT_YET_RECRUITINGAngers, 49000, France
-
University hospital
NOT_YET_RECRUITINGBordeaux, 33000, France
-
University hospital
NOT_YET_RECRUITINGBrest, 29000, France
-
University hospital
NOT_YET_RECRUITINGDijon, 21000, France
-
University hospital
NOT_YET_RECRUITINGGrenoble, 38000, France
-
University hospital
NOT_YET_RECRUITINGLille, 59000, France
-
University hospital
NOT_YET_RECRUITINGNancy, 54000, France
-
University hospital
NOT_YET_RECRUITINGNantes, 44000, France
-
University hospital
NOT_YET_RECRUITINGRennes, 35000, France
-
University hospital
NOT_YET_RECRUITINGSaint-Etienne, 42000, France
-
University hospital
NOT_YET_RECRUITINGToulouse, 31000, France
-
university hospital, Tours
RECRUITINGTours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden weight problem: PKU adults face higher obesity risk, scientists investigate why
- New oral drug aims to tame PKU's toxic protein buildup
- Experimental enzyme injection aims to tame PKU's toxic amino acid
- Tiny tablets could make PKU management easier for patients
- New PKU drug JNT-517 moves to Long-Term safety trial
- New pill for PKU shows promise in small teen trial